The Marketing Authorisation for Global Health Products (hereinafter referred to as MAGHP) procedure is a Swissmedic project in the area of regulatory systems strengthening. The aim of...
To all Applicants: Kindly note that COVID-19 Clinical Trial Applications do not follow the above predetermined submission due dates. They can be submitted to SAHPRA at any time. The last COVID-19 CTC meeting for 2022 is on the 09 December 2022 and the submission due...
Given that there is currently no credible evidence to support a therapeutic role for Ivermectin in COVID-19, SAHPRA has decided to terminate the Programme with immediate effect.
2020 Mar...
This document has been archived....
This document has been archived....
This document has been archived.
This document is intended to provide communication to applicants wishing to submit variations to existing registrations. This will be a “living document” and will be updated. Kindly note that this is an interim document and that the information will be incorporated into a General Information...
2020 Sep...